Recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase (PAH) (NGGT)

N/A

Report date: 2023/03/06 09:52:27

Base Information

Drug NameRecombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase (PAH) (NGGT)
Drug Alias NamerAAV-8 encoding hPAH (NGGT)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPhenylalanine hydroxylase stimulants
TargetsPhenylalanine hydroxylase
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Nuojiebei Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A